AmBisome liposomāls amfotericīns B 50 mg pulveris infūziju šķīduma pagatavošanai clinical trials

A Phase 2, monocentric, prospective, nonrandomized, open-label, experimental study to evaluate efficacy and safety of intrabronchial instillation of liposomal Amphotericin B in patients with simple pulmonary aspergilloma.

This study is testing a new way to deliver a medicine called Amphotericin B to treat a lung infection caused by a fungus, called simple aspergilloma. Doctors want to see if this new method can shrink the infection and if it's safe for patients.